Macular Edema Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Macular Edema stocks.

Macular Edema Stocks Recent News

Date Stock Title
Mar 18 CLSD Clearside Biomedical appoints Chong as CMO
Mar 18 REGN US appeals court revives Regeneron's antitrust lawsuit against Novartis
Mar 18 CLSD Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
Mar 18 KALV KalVista Pharmaceuticals Presents Real-World Data on Burden of Treatment and HAE Attack Journey at the 2024 HAEi Regional Conference Americas
Mar 17 REGN 11 Oversold Biotech Stocks To Buy Right Now
Mar 17 REGN Regeneron Pharmaceuticals Insiders Sold US$26m Of Shares Suggesting Hesitancy
Mar 14 REGN Cardiff Oncology (CRDF) Moves 20.5% Higher: Will This Strength Last?
Mar 14 CLSD Clearside Biomedical Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
Mar 13 REGN Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners Global Biopharma Conference (Transcript)
Mar 13 CLSD Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript
Mar 13 CLSD Q4 2023 Clearside Biomedical Inc Earnings Call
Mar 13 CLSD Clearside Biomedical, Inc. (CLSD) Q4 2023 Earnings Call Transcript
Mar 13 REGN High School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and Mathematical Optimization
Mar 12 CLSD Clearside Biomedical Inc (CLSD) Reports Significant Licensing Revenue Growth in Q4 and Full ...
Mar 12 CLSD Clearside Biomedical GAAP EPS of -$0.08 beats by $0.01, revenue of $6.35M beats by $2.11M
Mar 12 CLSD Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Mar 12 REGN Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Barclays 26th Annual Global Healthcare Conference (Transcript)
Mar 12 REGN Regeneron (REGN) Gets FDA Nod for Praluent Label Extension
Mar 12 REGN ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
Mar 12 KALV KalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for Sebetralstat
Macular Edema

Macular edema is a condition in which fluid accumulates in the macula, the part of the eye responsible for central vision. It can cause blurred vision, difficulty reading, and other vision problems. Macular edema can be caused by a variety of conditions, including diabetes, retinal vein occlusion, and uveitis. Treatment may include medications, laser therapy, or surgery.

Browse All Tags